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Abstract
Background: Peripheral nerve injury (PNI) is a worldwide issue associated with severe social and economic burden.
Autologous nerve grafting, the gold standard treatment for peripheral nerve defects, still has a number of technical
limitations. Tissue engineering technology is a novel therapeutic strategy, and mesenchymal stromal cells (MSCs)
are promising seed cells for nerve tissue engineering. However, the efficiency of traditional methods for inducing
the differentiation of MSCs to Schwann cell-like cells (SCLCs) remains unsatisfactory.
Methods: Here, we propose an intermittent induction method with alternate use of complete and incomplete induction
medium to induce differentiation of adipose-derived stem cells (ASCs) to SCLCs. The time dependence of traditional
induction methods and the efficiency of the intermittent induction method and traditional induction methods were
evaluated and compared using immunocytochemistry, quantitative reverse transcription polymerase chain reaction
(qRT-PCR), enzyme-linked immunosorbent assay (ELISA), and co-culture with the dorsal root ganglion (DRG) in vitro.
Cell transplantation was used to compare the effects of the traditional induction method and the intermittent induction
method in repairing sciatic nerve defects in vivo.
Results: The results of the present study indicated that the intermittent induction method is more efficient than
traditional methods for inducing ASCs to differentiate into SCLCs. In addition, SCLCs induced by this method
were closer to mature myelinating Schwann cells and were capable of secreting neurotrophins and promoting
DRG axon regeneration in vitro. Furthermore, SCLCs induced by the intermittent induction method could repair sciatic
nerve defects in rats by cell transplantation in vivo more effectively than those produced by traditional methods.
Conclusion: Intermittent induction represents a novel strategy for obtaining seed cells for use in nerve tissue engineering.
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Background
Peripheral nerve injury (PNI) affects 1 million people
every year worldwide [1, 2]. There are nearly 300,000
traumatic PNI cases in Europe every year. In addition,
PNI accounts for as many as 3% of all trauma patients
in the United States, which increases to 5% if plexus and
root avulsions are taken into consideration [3, 4]. End-
to-end suturing is sufficient for treatment in cases of
simple nerve transection. However, in the majority of
cases, simple suturing is not applicable because of the
large distance between proximal and distal stumps.
Autologous nerve grafting is the gold standard treatment
for this type of PNI [5, 6]. Autologous nerves provide a
physical and biological scaffold to induce axon growth
through the defect area, thus reconstructing the con-
tinuity of nerves [7, 8]. There are a number of technical
limitations in autologous nerve grafting, such as limited
donor sources, complications from second operations,
and risk of painful neuroma formation [5, 9, 10]. There-
fore, peripheral nerve repair using synthetic or bio-
derived transplants has aroused widespread attention.
Tissue engineering technology is a novel therapeutic
strategy for peripheral nerve defects [11]. The typical
composition of tissue-engineered nerve grafts includes
scaffold material, seed cells, and neurotrophic factors.
Schwann cells (SCs) or cells with similar functions are
promising as seed cells for tissue-engineered nerve
grafts. Unfortunately, in clinical application, SCs face dif-
ficulties with regard to isolation, proliferation, and puri-
fication, as well as donor site complications [12–14].
Moreover, residual fibroblasts remain during SC culture
and proliferate much more rapidly than SCs [11]. This
would become a severe problem for peripheral nerve re-
generation because scars will form if SCs are trans-
planted along with large numbers of fibroblasts [15].
Therefore, seed cell sources with extensive self-renewal
capacity, broad differentiation potential, low immuno-
genicity, and readily accessible properties are urgently
needed [16].
Mesenchymal stromal cells (MSCs), which are derived
from self-renewing multipotent adult precursors in the
mesoderm germ layer, are promising seed cells for tissue
engineering [17]. They have the capacity to differentiate
into mesodermal lineage cells, including osteoblasts,
chondroblasts, and adipocytes [18]. Indeed, MSCs are
heterogeneous and contain several populations, includ-
ing stem cells. After their adherent culture and cell ex-
pansion in vitro, the purified stem cells from MSCs are
divided into different categories depending on where
they come from, such as bone marrow-derived stem
cells (BMSCs) and adipose-derived stem cells (ASCs)
[19]. Although BMSCs are the most studied type of
MSCs for use in SC differentiation, their clinical applic-
ability is still limited because of their low yield and high
degree of invasiveness [20]. The proliferation capability
and differentiation potential of BMSCs also decreases
with increasing donor age [16]. It has been reported that
Schwann cell-like cells (SCLCs) derived from BMSCs
and ASCs can promote nerve regeneration. However,
ASCs have a number of advantages in comparison with
BMSCs, including lower invasiveness of acquisition,
abundance, rapid rate of expansion in vitro, and are cap-
able of long-term survival and integration in host tissues
with immunological tolerance [21].
ASCs have been shown to be able to differentiate into
SCLCs with expression of neurogenic growth factors in
vitro which promote myelination and axonal regener-
ation in PNI animal models [22–24]. The most common
means of inducing differentiation of ASCs into SCLCs
are the Dezawa and Kingham methods [25, 26]. How-
ever, neither of these methods has satisfactory efficiency
since the surface markers of SCs, such as S100 and glial
fibrillary acidic protein (GFAP), have relatively low ex-
pression rates (approximately 30–60% positive). In
addition, the apoptosis of many unsuccessfully differenti-
ated ASCs would further reduce S100 and GFAP expres-
sion [27–30]. The time span of induction during the
sustaining induction period following pre-induction is
not consistent in both the Dezawa and Kingham
methods [28, 31–33]. Studies have shown that the effi-
ciency of inducing differentiation of BMSCs into SCLCs
exhibited time dependence in the sustaining induction
period, and the optimal sustaining induction period is
5–6 days [34, 35].
Here, we simulated the process of MSC induction into
adipocytes with the application of a novel method to in-
duce differentiation of ASCs into SCLCs by the alternate
use of complete and incomplete induction medium. This
intermittent induction method can strongly promote dif-
ferentiation of ASCs into SCLCs, thus providing high-
quality seed cells for tissue-engineered nerve grafts.
Methods
Animals
The experimental procedures involving laboratory ani-
mals were approved by the Institutional Animal Care
and Use Committee of the Chinese PLA General
Hospital and were performed in accordance with the
Guidelines for the Care and Use of Laboratory Animals
from the Chinese Ministry of Public Health and US Na-
tional Institutes of Health. Sprague–Dawley (SD) rats
used in the experiments were obtained from the Labora-
tory Animal Research Center of Chinese PLA General
Hospital and housed in a temperature-controlled envir-
onment under a 14 h/10 h light/dark cycle. All proce-
dures described below were carried out during the light
period of the cycle and all surgical procedures were
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performed under general anesthesia with intraperitoneal
injection of pentobarbital.
Isolation and culture of adipose-derived stem cells and
Schwann cells
ASCs were isolated from the inguinal fat region of 3-
week-old SD rats. The fat was then cut into chyliform
and digested with collagenase II (1.5 mg/ml; C6885;
Sigma) dissolved in Dulbecco’s modified Eagle’s
medium/Ham’s F-12 50/50 mix (DMEM/F-12; Corning)
for 30 min at 37 °C. The cells were harvested by enzyme
digestion and cultured in α-modified minimal essential
medium (α-MEM) (SH30265; Hyclone) with 10% fetal
bovine serum (FBS) (35–011-CV; Corning) at 37 °C
under an atmosphere of 5% CO2 following centrifuga-
tion and resuspension. ASCs were able to grow adhering
to the wall and were further passaged when they had
reached 80% confluency. Cells at passage 2 were used
for all subsequent experiments.
SCs were harvested from the sciatic nerves of 3-day-old
SD rats. Briefly, lengths of approximately 1 cm of the sci-
atic nerves were cut, and the epineurium was removed
under a microscope. The sciatic nerves were then cut into
small pieces approximately 1 mm in length and enzymati-
cally dissociated in collagenase NB4 (2 mg/ml; 17,454;
SERVA) dissolved in DMEM/F-12 for 15 min at 37 °C,
centrifuged, and resuspended in DMEM/F-12 containing
10% FBS. SCs obtained by the above method were cul-
tured in an incubator at 37 °C under an atmosphere of 5%
CO2. After 48 h, the supernatant was removed and SCs
were resuspended in 1 mg/ml collagenase NB4 to purify
these cells from fibroblasts. The purified SCs were used
for all subsequent experiments.
Multipotential differentiation of adipose-derived stem cells
ASCs at passage 2 were induced to undergo adipogenic,
osteogenic, and chondrogenic differentiation to identify
the characteristics of multidifferentiation. For adipogenic
differentiation, ASCs were seeded in six-well plates at a
density of 2 × 105 cells/well. SD rat adipose-derived stem
cell adipogenic differentiation medium (RASMD-90031;
Cyagen Biosciences Inc.) was used to induce adipogenic
differentiation after cells had reached confluence. The
induction/maintenance media were replaced alternately
for three cycles of 3 days/1 day. Differentiated cells were
fixed and stained with Oil Red O working solution (3:2
dilution with distilled water and Filter with filter paper)
for 30 min. For osteogenic differentiation, ASCs were
seeded in six-well plates at a density of 1 × 105 cells/well.
SD rat adipose-derived stem cell osteogenic differenti-
ation medium (RASMD-90021; Cyagen Biosciences Inc.)
was used to induce osteogenic differentiation when cells
had reached 70% confluence, and completely replaced by
fresh medium every 3 days for 3 weeks. Differentiated
cells were fixed and stained with Alizarin Red working
solution for 5 min. For chondrogenic differentiation,
ASCs were resuspended in medium following digestion
with 0.25% trypsin (25,200,056; Gibco), and aliquots of
5 × 105 cells were centrifuged in 15-ml polypropylene
culture tubes. SD rat adipose-derived stem cell chondro-
genic differentiation medium (RASMD-90042; Cyagen
Biosciences Inc.) was added to the cell pellet used to in-
duce chondrogenic differentiation at 37 °C in a humidi-
fied atmosphere of 5% CO2 after discarding the
supernatant. The complete chondrogenic medium was
replaced every 3 days for 21 days. Chondrogenic pellets
were fixed in 4% paraformaldehyde (P1110; Solarbio)
and 5-μm thick paraffin sections were cut. The sections
were stained with Toluidine Blue O solution (1% in so-
dium borate; G3663; Solarbio) for 5 min. Images were
captured using a microscope equipped with a DP71
camera (BX51; Olympus).
Flow cytometry
ASCs were resuspended following digestion with 0.25%
trypsin and washed three times with phosphate-buffered
saline (PBS). A minimum of 1 × 105 cells were collected
from each sample. Samples were incubated with
phycoerythrin (PE)-coupled antibodies against rat CD29
(562,154; BD Biosciences), CD34 (sc-7324; Santa Cruz),
CD45 (554,878; BD Biosciences), CD86 (551,396; BD
Biosciences), and CD90 (551,401; BD Biosciences), and
fluorescein isothiocyanate (FITC)-coupled antibody
against rat CD44 (550,974; BD Biosciences) in the dark
at room temperature for 30 min. Nonspecific isotype-
matched antibodies were used as controls. The samples
were subjected to flow cytometry, and data were ana-
lyzed using Paint-A-Gate Pro™ software (FACSCalibur™;
BD Biosciences).
Experimental design and differentiation into Schwann
cell-like cells
In this study, we improved the traditional methods for in-
ducing the differentiation of MSCs into SCLCs. The ex-
perimental grouping and specific induction methods were
as follows (Fig. 1f): (i) uASCs: undifferentiated ASCs
(uASCs) at passage 2 were used; (ii–v) ASCs at passage 2
were pre-induced for 24 h with pre-induction medium I
consisting of serum-free Dulbecco’s modified Eagle’s
medium (DMEM) containing 1 mM β-mercaptoethanol
(β-ME) (M3148; Sigma). Pre-induction medium I was re-
placed with pre-induction medium II consisting of
DMEM, 10% FBS, and 35 ng/ml all trans-retinoic acid
(RA) (R2625; Sigma) and incubated for 72 h. The resulting
differentiated ASCs were divided into four groups accord-
ing to subsequent processing: (ii) sustaining dASCs 4d:
Differentiated ASCs (dASCs) were induced for 4 days with
complete induction medium consisting of DMEM, 10%
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FBS, 5 μM forskolin (F6886; Sigma), 200 ng/ml recombin-
ant human heregulin-β1 (HRG) (100–03; PeproTech),
10 ng/ml basic fibroblast growth factor (bFGF) (3339-FB:
R&D Systems), and 5 ng/ml recombinant rat platelet-
derived growth factor (PDGF)-AB (1115-AB; R&D Sys-
tems); (iii) sustaining dASCs 7d: dASCs were induced for
7 days with complete induction medium; (iv) sustaining
dASCs 10d: dASCs were induced for 10 days with complete
induction medium; (v) intermittent dASCs: dASCs were in-
duced for 4 days with complete induction medium, after
which complete induction medium was replaced with in-
complete induction medium consisting of DMEM, 10%
FBS, 5 μM forskolin, and 200 ng/ml HRG for induction for
3 days. Immediately after this procedure, complete induc-
tion medium was again used to induce differentiation for
3 days; and (vi) SCs: primary Schwann cells.
Fig. 1 Identification of adipose-derived stem cells (ASCs) and schematic of the experimental design. a Primary ASCs grew in clusters and had a
rounded spindle-like shape. b ASCs at passage 2 could differentiate into adipocytes, and the visual field in photographs was filled with red lipid
droplets stained with Oil Red O solution. c ASCs differentiated into osteocytes formed calcium nodules with burrs, which were stained red by
Alizarin Red solution. d In cartilage pellets, many cartilage lacunae were found, and the glycosaminoglycans around the chondrocytes were stained
purple-blue by Toluidine Blue O solution. e Flow cytometry showed that more than 98% of ASCs were immunopositive for the MSC markers CD29,
CD44, and CD90, while less than 6% of ASCs were immunopositive for the hematopoietic stem cell markers CD34, CD45, and CD86. f Schematic
showing the experimental groups and induction methods. bFGF, basic fibroblast growth factor; β-ME, β-mercaptoethanol; dASC, differentiated ASC;
DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; PDGF, platelet-derived growth factor; SC, Schwann cell; uASC, undifferentiated ASC
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Quantitative reverse transcription polymerase chain reaction
(qRT-PCR)
Aliquots of more than 1 × 106 cells were used to
determine the specific gene expression profiles of cells in
each group. Total RNA was extracted using an RNeasy
Mini Kit (74,104; Qiagen) and quantified using a Nucleic
Acid and Protein Analyzer (Microfuge18; Beckman-
Coulter). The extracted RNA was reverse transcribed into
complementary DNA (cDNA) using a ReverTra Ace®
qPCR RT Kit (FSQ-101; TOYOBO). qRT-PCR was per-
formed using a StepOne™ Real-Time PCR System (Ap-
plied Biosystems). Briefly, 1 μl of cDNA and 1 μl of
specific primer pairs (Table 1) were used for qRT-PCR
with DNA polymerase from the SYBR® Green Realtime
PCR Master Mix-Plus (QPK-212; TOYOBO). The PCR
amplification reaction was performed in a final volume of
20 μl under the following conditions: 1 min at 95 °C for
enzyme activation, followed by 40 cycles of 15 s at 95 °C
for denaturation, 15 s at 57 °C for annealing, and 45 s at
72 °C for extension. All data were analyzed using
StepOne™ software version 2.2 (Applied Biosystems). Rela-
tive levels of gene expression were normalized to the level
of the housekeeping gene, glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH), and expressed as a ratio relative
to uASCs. All detections were repeated three times
independently.
Enzyme-linked immunosorbent assay (ELISA)
Cells in each group were resuspended in DMEM/F-12
containing 5% FBS and seeded in 25-cm2 cell culture
flasks at a density of 3 × 104 cells/cm2. The medium was
collected and centrifuged at 1500 rpm at 4 °C for 10 min
after 48 h of incubation. The concentrations of nerve
growth factor (NGF), brain-derived neurotrophic factor
(BDNF), glial cell line-derived neurotrophic factor
(GDNF), and ciliary neurotrophic factor (CNTF) in the
supernatant of each group were examined by ELISA
using Rat NGF/NGF beta ELISA Kit (EK0471; Boster),
Rat BDNF ELISA Kit (EK0308; Boster), Rat GDNF
ELISA Kit (EK0363; Boster), and Rat CNTF ELISA Kit
(EK0324; Boster), respectively. The absorbances of each
well at 450 nm were determined using a trace orifice
spectrophotometer (EPOCH TAKE 3; BioTek). The
standard curve was drawn using the data produced from
the diluted standard solutions with CurveExpert version
1.4. The concentrations of NGF, BDNF, GDNF, and
CNTF were calculated according to the standard curve.
All detections were repeated four times independently.
Isolation of dorsal root ganglion and co-culture with
uASCs/dASCs/SCs in a Transwell® system
Briefly, after sterilizing 12-h-old suckling SD rats in 75%
ethanol solution, the spine was completely removed, and
the blood was washed away with PBS. The spine was
then dissected into two halves along the mid-sagittal
plane, and the dorsal root ganglia (DRG) were removed
from the ambilateral intervertebral foramen under a
microscope. The epineurium of the DRG was carefully
stripped using microforceps in cryic DMEM/F-12
medium supplemented with 10% FBS. DRG stripped
from the epineurium were seeded in the lower chambers
of a Transwell® system (3450; Corning) with six inserts,
24 mm in diameter with 0.4-μm pore size polyester
membrane in six-well plates (Additional file 1: Figure
S1). The six groups of cells were resuspended and
seeded in the upper inserts of the Transwell® system at a
density of 3 × 104 cells/cm2 (Additional file 1: Figure S1).
Neurobasal®-A Medium (10888–022; Gibco)
supplemented with B-27® Serum-Free Supplement (1:50;
17,504–044; Gibco) and GlutaMAX™ Supplement (1:100;
35,050–061; Gibco) was used to co-culture the six
groups of cells and DRG. After co-culture for 3 days, im-
munofluorescence staining of neurofilament protein 200
(NF200) and S100 was performed to evaluate the effects
of each group of cells acting on the DRG. See the
Immunofluorescence section below for detailed staining
steps. Five randomly selected DRG from each group
were imaged by integral photography. The three longest
axons per quadrant (a total of four quadrants) were
measured and used to calculate the mean axons length
of each DRG using Image Pro Plus 6.0 (IPP 6.0; Media
Cybernetics) image analysis software, as well as the
Table 1 List of primer sequences used in this study
Target genes Forward primer (5’–3’) Reverse primer(5’–3’) Annealing temperature (°C)
GAPDH ATGGTGAAGGTCGGTGTGAACG TTACTCCTTGGAGGCCATGTAG 55–62
P0 GCTCTTCTCTTCTTTGGTGCTGTCC GGCGTCTGCCGCCCGCGCTTCG 57
NGFR p75 ATGAGGAGGGCAGGTGCTG TCACACTGGGGACGTGGC 55
GFAP GGACATCGAGATCGCCACCTACAG CATCCCGCATCTCCACCGTCTTTAC 57
NGF ATGTCCATGTTGTTCTACAC TCAGCCTCTTCTTGCAGCC 56
BDNF ATGACCATCCTTTTCCTTAC CTATCTTCCCCTTTTAATGG 57
CNTF ATGGCTTTCGCAGAGCAAA CTACATCTGCTTATCTTTGGCC 56
BDNF, brain-derived neurotrophic factor; CNTF, ciliary neurotrophic factor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GFAP, glial fibrillary acidic protein;
NGF, nerve growth factor; NGFR p75, nerve growth factor receptor p75; P0, myelin protein zero
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farthest migration distance of SCs by calculating the dis-
tance between the three farthest SCs per quadrant and
the DRG border. In addition, the ratio of S100-positive
cells in each randomly selected DRG area was deter-
mined using IPP 6.0.
Immunofluorescence
DRG co-cultured with six groups of cells in the Trans-
well® system and six groups of cells not from the Trans-
well® system were rinsed with PBS and fixed in 4%
paraformaldehyde for 10 min at room temperature after
removing the medium. Subsequently, the DRG and cells
were blocked at room temperature with 10% goat serum
(SL038; Solarbio) in PBS for 1 h after washing three
times with PBS for 5 min each time. Mouse anti-S100
(1:1000; S2532; Sigma) and Rabbit anti-p75 NGF Recep-
tor antibodies (1:500; ab8874; Abcam) were used as the
primary antibodies for the six groups of cells. Mouse
anti-Neurofilament 200 (1:800; N0142; Sigma) and
Rabbit anti-S100 antibodies (1: 200; S2644; Sigma) were
applied as the primary antibodies for DRG. After incuba-
tion with the respective primary antibodies in a humidi-
fied chamber overnight at 4 °C, DRG and cells were
rinsed three times with PBS. Subsequently, Goat Anti-
Mouse IgG H&L (Alexa Fluor® 488; 1:200; ab150117;
Abcam) and Goat Anti-Rabbit IgG H&L (Alexa Fluor®
594; 1:200; ab150084; Abcam) secondary antibodies were
applied and incubated with DRG and cells in the dark
for 1 h at room temperature. Finally, the nuclei were
counterstained with 4’,6-diamidino-2-phenylindole
(DAPI) after washing three times with PBS. All images
were captured using a microscope equipped with a
DP71 camera. The number of surviving cells, and the
rates of S100- and NGFR p75-positive cells in the six
groups of cells (not from the Transwell® system) were
calculated according to 10 randomly selected fields of
each group at 200× magnification using IPP 6.0.
Cell transplantation for the treatment of peripheral nerve
defects
Fifty male SD rats, 12 weeks old and weighing 300–
350 g, were anesthetized by intraperitoneal injection of
3% sodium pentobarbital solution (30 mg/kg body
weight), and the hair on the left thigh was removed. The
posterolateral skin of the left thigh was sterilized and in-
cised. The sciatic nerve was carefully exposed and iso-
lated from the intermuscular space. A 7-mm segment of
the sciatic nerve was transected and removed using
sharp microsurgery scissors, leaving a 10-mm defect
after retraction of the nerve stumps. The rats were ran-
domly separated into five groups (n = 10/group) accord-
ing to the different types of nerve graft used to bridge
the sciatic nerve defect: (A) hollow, in which only a bio-
degradable chitin conduit 10 mm in length (outer
diameter, 2 mm; internal diameter, 0.8 mm) was used;
(B) uASCs; (C) sustaining dASCs 7d, in which the differ-
entiation effect was greatest among the sustaining induc-
tion groups in vitro; (D) intermittent dASCs; and (E)
autograft, in which an autologous nerve graft was ap-
plied. In all groups involving cell transplantation, the
biodegradable chitin conduits were injected with 10 μl
of a mixture of fibrin glue and 5 × 105 cells to construct
different nerve grafts. Epineurial sutures were used to
secure nerve grafts using an 8/0-swaged needle under an
operating microscope. All rats were reared under
standard laboratory conditions as described previously.
The chitin conduits were provided by the Department of
Orthopaedics and Trauma, Peking University People’s
Hospital, and were patented by Peking University
People’s Hospital and Textile Science Institute of China
(Patent Number: 01136314.2).
Gait analysis
Gait analysis was performed 2, 4, 6, 8, 10, and 12 weeks
after transplantation to assess the recovery of motor
function. A CatWalk footprint analysis system (XT 10.6;
Noldus) was used to collect footprints, and the assess-
ment process was as follows. Rats in each group were
placed on the walkway floor; when the paws touched the
glass floor, the dynamic properties changed due to the
pressure, and fluorescence escaped internal reflectance.
Thus, only the contact area of the paws was visible and
the footprint appeared brighter when the paws provided
more pressure. When the rat entered a 40 × 10 cm field
on the walkway, the run was captured by a video camera
underneath the walkway floor. The run was approved if
the rat passed the monitored field within 5 s and the
speed showed less than 50% variation. At least three ap-
proved runs were needed for each group per time point
for the analysis. All acquired data were processed in a
semiautomated manner using the Noldus Catwalk ana-
lysis software, which required manual definition of the
limb (LH = left hind, RH = right hind) from the recorded
run. The sciatic functional index (SFI) and stand/swing
time ratio of each rat were calculated using CatWalk XT
10.6 according to the measurement results.
Electrophysiology
Neural electrophysiological evaluation was performed at
the twelfth week after transplantation. Five rats in each
group were anesthetized with 3% sodium pentobarbital
solution. The previous surgical site on the left femur was
re-opened, and the postoperative sciatic nerves and
gastrocnemius of each rat were exposed. The compound
muscle action potentials (CMAPs) were induced and re-
corded using a fully functional electromyography ma-
chine (Keypoint; Medtronic), the bipolar stimulating
electrodes of which were placed sequentially on the
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proximal and distal ends of each graft and the monopolar
recording electrode was placed on the belly of the ipsilat-
eral gastrocnemius. The CMAPs of the contralateral nor-
mal sciatic nerve were also recorded for normalization.
Electrical stimulation was performed at 3.0 mA and 1 Hz.
The peak amplitude and latency of CMAPs were used to
evaluate the recovery of nerve conduction function, and
the acquired data were expressed as the ratio of the in-
jured side to the normal side.
Histological evaluation of grafting segment following cell
transplantation
Five rats in each group were sacrificed by intraperitoneal
injection of a sodium pentobarbital overdose in week 6
following cell transplantation. The implanted nerve
grafts were clearly exposed and integrally excised. Cross-
sections of each nerve graft midpoint were cut into
7-μm thick paraffin sections and placed in Sodium
Citrate Antigen Retrieval Solution (C1032; Solarbio) for
10 min at 95 °C after deparaffinization. The sections were
then transferred to PBS containing 10% goat serum to
block heterogenetic antigens for 30 min at room
temperature after washing three times with PBS for 5 min
each time. The primary antibodies Rabbit anti-myelin pro-
tein zero (P0) (1: 100; ab31851; Abcam) and Mouse anti-
NF200 (1:800; N0142; Sigma) were used to incubate sec-
tions in a humidified chamber overnight at 4 °C. Next
morning, Goat Anti-Mouse and Goat Anti-Rabbit IgG
H&L secondary antibodies were applied to the sections
and incubated in the dark for 1 h at room temperature
after rinsing off excess primary antibodies with PBS. After
washing three times with PBS, the nuclei were counter-
stained with DAPI. Ten randomly selected fields of each
group at 400× magnification were captured to count the
mean density of myelinated nerve fibers by IPP 6.0.
At week 12 after transplantation, the rats were sacri-
ficed by intraperitoneal injection of an overdose of so-
dium pentobarbital following electrophysiological
evaluation. The regenerative nerves located at the distal
ends of the nerve grafts were fixed to cut transverse
semi-thin sections at a thickness of 1 μm using a glass
knife in an ultramicrotome (EM UC7; Leica) and stained
with Toluidine Blue O solution (1% in sodium borate;
G3663; Solarbio). The stained sections were observed
under 400× magnification, and 10 randomly selected
fields were captured for each group to count the mean
density of myelinated nerve fibers by IPP 6.0. Subse-
quently, the regenerative nerves were cut into transverse
ultrathin sections 70 nm thick using a diamond knife in
an ultramicrotome (EM UC7; Leica) and collected on
copper slot grids with pioloform/carbon support films.
The ultrathin sections were counterstained with 3% lead
citrate and uranyl acetate, and were observed by trans-
mission electron microscopy (TEM) (CM-120; Philips).
Ten randomly selected fields at 5000× magnification
were captured for each group to measure the mean
diameter of myelinated nerve fibers and the mean thick-
ness of the myelin sheath by IPP 6.0.
Ultrasonic and histological evaluation of the gastrocnemius
Ultrasonic elastography was used to evaluate the muscle
activity of the gastrocnemius at the sixth week after
transplantation. Briefly, rats from each group were anes-
thetized with 3% sodium pentobarbital solution (30 mg/
kg body weight) and the hair was removed from the
paired hind limbs. The body surface projective regions
of the bilateral gastrocnemius were fully exposed. A
color Doppler ultrasound diagnostic instrument (Apo-
lio500; TOSHIBA) was applied to locate the gastrocne-
mius using two-dimensional imaging. Subsequently, the
instrument was switched to the shear wave elastography
(SWE) mode, and the sampling frame was adjusted using
the continuous excitation mode without pressing on the
ultrasonic probe. The image was frozen and regulated to
the speed propagation pattern after it had stabilized. Im-
ages with good isochrone were selected, and the area of
interest was selected using the acquiescent circle to
automatically record Young’s modulus and standard de-
viation, which were used for statistical analyses.
At the twelfth week after transplantation, the bilateral
gastrocnemius muscles of rats in each group were excised
and immediately weighed to calculate the wet weight recov-
ery ratio of the gastrocnemius (injured side/normal side)
after electrophysiological evaluation. The gastrocnemius
muscle belly was harvested and fixed in 4% formaldehyde
for 2 h. Transverse paraffin sections of the gastrocnemius
muscle belly 10 μm thick were cut and stained using a
modified Masson’s trichrome stain kit (G1345; Solarbio).
Ten randomly selected fields in each group at 200× magni-
fication were captured to measure the mean cross-sectional
area of the gastrocnemius fibers by IPP 6.0.
Statistical analysis
All data are presented as the means ± standard deviation
(SD) from three or more independent experiments. Statistical
analysis was performed using SPSS (version 22.0; IBM).
Student’s t test was performed to compare differences be-
tween two groups, and one-way analysis of variance
(ANOVA) was used to compare differences between multiple
groups. Tukey’s post-hoc test was applied when p > 0.05 in
the test of homogeneity of variances, otherwise Dunnett’s T3
post-hoc test was applied. Differences between groups were
considered significant at **p < 0.01 and *p < 0.05.
Results
Identification of adipose-derived stem cells
Primary ASCs grew in clusters and had a rounded
spindle-like shape (Fig. 1a). ASCs at passage 2 could
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differentiate into adipocytes, and the visual field in pho-
tographs was filled with red lipid droplets stained with
Oil Red O solution (Fig. 1b). Upon osteogenic differenti-
ation, differentiated ASCs showed calcium nodule de-
position with burrs, which stained positively with
Alizarin Red solution (Fig. 1c). Many cartilage lacunae
were found in cartilage pellets, which were induced from
ASCs. In addition, glycosaminoglycans around the chon-
drocytes induced from ASCs were stained purple-blue
by Toluidine Blue O solution (Fig. 1d). Flow cytometry
showed that more than 98% of ASCs were immunoposi-
tive for the MSC markers CD29, CD44, and CD90, while
less than 6% of ASCs were immunopositive for the
hematopoietic stem cell markers CD34, CD45, and
CD86 (Fig. 1e).
Characteristics of Schwann cell-like cells
uASCs had a spindle-like shape, although very few
expressed S100 protein, an important marker of SCs,
and more than 60% were immunopositive for NGFR p75
(Fig. 2a–c). These results indicated that ASCs had the
potential to differentiate into glial cells. With extension
of the induction period, the dASCs became morpho-
logically more similar to SCs, exhibiting a narrow
fusiform-like shape with a bipolar or tripolar structure,
and the rate of S100-positive cells labeled with green
fluorescence also increased gradually (Fig. 2a, b). How-
ever, the number of surviving cells in each sustaining
dASC group decreased gradually with induction time
due to apoptosis of unsuccessfully differentiated ASCs,
which indirectly increased the rate of S100-positive cells.
Among them, the number of surviving cells in sustaining
dASCs 10d (33.50 ± 7.74) was significantly less (p < 0.05)
than that in intermittent dASCs (46.40 ± 9.00), sustain-
ing dASCs 4d (61.50 ± 8.32), and sustaining dASCs 7d
groups (59.00 ± 9.85) (Fig. 2a, d). In the meantime, the
rate of S100-positive cells in the intermittent dASCs
group (86.78 ± 6.03%) was not significantly different
compared with that in sustaining dASCs 10d (71.89 ± 12.
37%) or SCs groups (88.60 ± 7.15%), but was significantly
higher (p < 0.05) than the uASCs (6.80 ± 2.44%), sustain-
ing dASCs 4d (34.90 ± 10.70%), and sustaining dASCs 7d
groups (72.81 ± 10.53%) (Fig. 2a, b). In addition, the rate
of NGFR p75-positive cells was not significantly different
among all six groups (Fig. 2a, c).
mRNA expression
To compare the differentiation effect at the molecular
level, the relative mRNA expression levels in each group
of cells were examined by qRT-PCR. The relative expres-
sion level of NGFR p75 mRNA was not significantly dif-
ferent among sustaining dASCs 7d (5.55 ± 0.29),
intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34),
which were significantly higher (p < 0.01) than the other
three groups (Fig. 3a). The relative expression level of P0
mRNA was highest in SCs (14.11 ± 0.88). There were no
significant differences between intermittent dASCs (8.46
± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However,
intermittent dASCs showed significantly higher (p < 0.
05) P0 mRNA expression in comparison with sustaining
dASCs 10d (6.00 ± 0.12) and sustaining dASCs 4d (2.66
± 0.19) (Fig. 3b). The relative expression level of GFAP
mRNA was not significantly different between intermit-
tent dASCs (4.62 ± 0.21) and the three sustaining dASCs
groups, all of which showed significant upregulation (p
< 0.01) in comparison with the uASCs (Fig. 3c). The
relative mRNA expression levels of neurotrophins, in-
cluding NGF, BDNF, and CNTF, were also evaluated
(Additional file 2: Figure S2). There were no significant
differences in NGF, BDNF, or CNTF mRNA expression
levels between intermittent dASCs and sustaining
dASCs 7d, but all were significantly upregulated (p < 0.
01) compared with sustaining dASCs 4d and sustaining
dASCs 10d (Additional file 2: Figure S2a–c).
Secretion of neurotrophins
The neurotrophins secreted by the six groups of cells
were measured at the protein level by ELISA. The levels
of NGF secreted by intermittent dASCs (99.37 ± 5.00 pg/
ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were
significantly higher (p < 0.01) than those of uASCs (31.
18 ± 3.09 pg/ml) and sustaining dASCs 4d (54.69 ± 2.
20 pg/ml) and sustaining dASCs 10d (45.90 ± 2.27 pg/
ml), but were lower (p < 0.01) than that of SCs (112.46 ±
4.55 pg/ml) (Fig. 3d). A similar tendency was found for
CNTF (Fig. 3g). In addition, BDNF and GDNF secretion
levels also showed similar tendencies. The concentra-
tions of BDNF and GDNF secreted by intermittent
dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, re-
spectively, which were higher (p < 0.01) than in the other
groups, including SCs (Fig. 3e, f ).
Schwann cell-like cells mediated trophic effect on DRG
Immunofluorescence analysis revealed that the axons of
DRG exhibited green fluorescence, and SCs that mi-
grated from the DRG exhibited red fluorescence in the
lower chamber of the Transwell® system. Simultaneously,
all nuclei showed blue fluorescence (Fig. 4a). The mean
axon length of DRG in sustaining dASCs 7d (868.53 ±
34.22 μm), intermittent dASCs (1032.77 ± 109.91 μm),
and SCs (991.41 ± 68.23 μm) were significantly higher (p
< 0.01) than those in the other three groups, but there
were no significant differences within these three groups
(Fig. 4b). Although the ratio of SCs in sustaining dASCs
7d (72.62 ± 4.92%) was significantly higher (p < 0.01)
than those in uASCs (58.01 ± 2.74%), and sustaining
dASCs 4d (53.02 ± 4.03%) and sustaining dASCs 10d
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(53.22 ± 4.38%), the ratios in the above four groups were
significantly lower (p < 0.01) than in those in intermit-
tent dASCs (92.14 ± 3.44%) and SCs (93.95 ± 2.28%).
Moreover, the distributions of cells in uASCs and all
sustaining dASCs groups were serried, whereas those in
intermittent dASCs and SCs were homogeneous (Fig. 4a,
c). A similar tendency was observed for the mean axon
length of DRG, as the SCs showed significantly greater
(p < 0.01) migration distance from the DRG in sustaining
dASCs 7d (895.38 ± 34.80 μm), intermittent dASCs
(1033.19 ± 83.56 μm), and SCs (904.90 ± 36.83 μm) com-
pared with the other three groups, although there were
Fig. 2 Characteristics of Schwann cell (SC)-like cells derived from differentiated adipose-derived stem cells (dASCs) by sustaining/intermittent
induction methods. a In the leftmost column of optical microscope photographs, undifferentiated ASCs (uASCs) had a spindle-like shape and,
with extension of the induction period, the dASCs became morphologically more similar to SCs, exhibiting a narrow fusiform-like shape with a
bipolar or tripolar structure. In the immunofluorescence photographs, in the second column, S100-positive cells are stained with green fluorescence;
nerve growth factor receptor (NGFR) (p75)-positive cells are stained with red fluorescence in the third column. The blue fluorescence always
corresponds to cell nuclei. In the rightmost column of the immunofluorescence photographs, the three areas of fluorescence merge. b The
rate of S100-positive cells in intermittent dASCs group (86.78 ± 6.03%) was not significantly different compare to that in sustaining dASCs 10d
(71.89 ± 12.37%) or SCs groups (88.60 ± 7.15%), but was significantly higher (p < 0.05) than the uASCs (6.80 ± 2.44%), sustaining dASCs 4d
(34.90 ± 10.70%), and sustaining dASCs 7d groups (72.81 ± 10.53%). c The rate of NGFR (p75)-positive cells was not significantly different among all six
groups. d The number of surviving cells in sustaining dASCs 10d (33.50 ± 7.74) was significantly less (p < 0.05) than that in intermittent dASCs (46.40 ± 9.00),
sustaining dASCs 4d (61.50 ± 8.32), and 7d groups (59.00 ± 9.85). Data are expressed as means ± SEM. *p < 0.05, **p < 0.01, one-way ANOVA with Tukey’s
post-test or Dunnett’s T3 post-test. n.s., no significant difference
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no significant differences between these three groups
(Fig. 4d).
Functional recovery of the sciatic nerve following cell
transplantation
Functional recovery of the sciatic nerve was evaluated by
gait analysis. Representative two-dimensional (2D) and
three-dimensional (3D) stress diagrams of each group at
12 weeks after cell transplantation are shown in Fig. 5a.
According to the 2D stress diagrams, the period of con-
tact with the floor was markedly shorter for the left hind
(LH) leg on the injured side compared with the normal
right hind (RH) leg in hollow and uASCs groups, while
the contact times in the sustaining dASCs 7d and inter-
mittent dASCs groups were closer to that in the auto-
graft group. Furthermore, the intensity of pressure with
which the LH leg contacted the floor was markedly re-
duced in comparison with the RH leg in hollow and
uASC groups, but there were no significant differences
between the RH and LH legs in the sustaining dASCs 7d
or intermittent dASCs groups, as well as the autograft
group. Although the 3D stress diagrams showed less
contact area of the LH leg than the RH leg, the length
and width of the LH toes in sustaining dASCs 7d and
intermittent dASCs were improved compared with the
hollow and uASC groups, and were closer to those in
the autograft group (Fig. 5a).
The obvious advantage began to appear in the SFI in the
intermittent dASCs group at week 10 following cell trans-
plantation. The improvement of the SFI in the intermit-
tent dASCs group (−31.07 ± 2.24) was significantly
superior (p < 0.05) to those in the hollow (−49.58 ± 6.35),
uASCs (−48.88 ± 3.93), and sustaining dASCs 7d groups
(−41.14 ± 4.03) in the twelfth week after cell transplant-
ation, and showed no significant difference compared with
the autograft group (−25.09 ± 3.13) (Fig. 5b).
In the first 4 weeks, the stand/swing time ratio in inter-
mittent dASCs was always significantly lower (p < 0.05)
than those in the hollow, uASCs, and autograft groups.
The advantages of the intermittent dASCs group began to
appear at week 8 after cell transplantation. Until the last
time point, the stand/swing time ratio in the intermittent
dASCs (90.10 ± 2.25%) was significantly better (p < 0.05)
than those in the hollow (75.51 ± 2.80%), uASCs (75.13 ±
Fig. 3 Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve
growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ±
0.23), and SCs (5.54 ± 0.34), which were significantly higher (p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was
highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54).
However, intermittent dASCs showed significantly higher P0 mRNA expression (p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12)
and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between
intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation (p < 0.01) in comparison
with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ±
5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher (p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and
sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower (p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e,f Brain-derived
neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) secretion levels showed similar tendencies. The concentrations of
BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher (p < 0.01) than in the
other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ±
SEM. *p < 0.05, **p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no
significant difference, SC, Schwann cell
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Fig. 4 Effects of the secretions of each group of cells on dorsal root ganglia (DRG). a The axons of DRG exhibited green fluorescence and Schwann
cells (SCs) that migrated from the DRG exhibited red fluorescence in the lower chamber of the Transwell® system. Simultaneously, all nuclei showed
blue fluorescence. Moreover, the distributions of cells in undifferentiated adipose-derived stem cells (uASCs) and all sustaining differentiated (d)ASCs
groups were serried, whereas those in intermittent dASCs and SCs were homogeneous. Photographs in the bottom row are higher magnification
views of those in the box in the third row. b The mean axon length of DRG in sustaining dASCs 7d (868.53 ± 34.22 μm), intermittent dASCs (1032.77 ±
109.91 μm), and SCs (991.41 ± 68.23 μm) were significantly higher (p < 0.01) than those in the other three groups, but there were no significant
differences within the three groups. c Although the ratio of SCs in sustaining dASCs 7d (72.62 ± 4.92%) was significantly higher (p < 0.01) than those in
uASCs (58.01 ± 2.74%), and sustaining dASCs 4d (53.02 ± 4.03%) and 10d (53.22 ± 4.38%), the ratios in the above four groups were significantly lower
(p < 0.01) than in those in intermittent dASCs (92.14 ± 3.44%) and SCs (93.95 ± 2.28%). d A similar tendency was observed for the mean axon length of
DRG, as the SCs showed significantly greater (p < 0.01) migration distance from the DRG in sustaining dASCs 7d (895.38 ± 34.80 μm), intermittent
dASCs (1033.19 ± 83.56 μm), and SCs (904.90 ± 36.83 μm) compared with the other three groups, although there were no significant differences
between these three groups. Data are expressed as means ± SEM. **p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. n.s., no
significant difference,
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3.47%), and sustaining dASCs 7d groups (83.39 ± 3.68%)
(Fig. 5c).
Histological evaluation of regenerative nerves following
cell transplantation
At week 6 after cell transplantation, regenerated axons
labeled with green fluorescence with or without regener-
ated myelin sheaths labeled with red fluorescence were
observed at the midpoint of the implanted segments.
The nuclei were labeled with blue fluorescence (Fig. 6a).
The mean density of myelinated nerve fibers in intermit-
tent dASCs (15,520 ± 694/mm2) was significantly greater
(p < 0.01) than those in the hollow (8575 ± 779/mm2),
uASCs (7268 ± 637/mm2), and sustaining dASCs 7d
groups (13,814 ± 658/mm2) at week 6 after cell
transplantation. However, no significant difference was
Fig. 5 Gait analysis and sciatic functional recovery after cell transplantation. a Representative two-dimensional (2D) and three-dimensional (3D)
stress diagrams of each group at 12 weeks after cell transplantation. b The obvious advantage began to appear in the SFI in the intermittent
dASCs group at week 10 following cell transplantation. The improvement of the SFI in the intermittent dASCs group (−31.07 ± 2.24) was significantly
superior (p < 0.05) to those in the hollow (−49.58 ± 6.35), uASCs (−48.88 ± 3.93), and sustaining dASCs 7d groups (−41.14 ± 4.03) in the twelfth week
after cell transplantation, and showed no significant difference compared with the autograft group (−25.09 ± 3.13). c In the first 4 weeks, the stand/
swing time ratio in intermittent dASCs was always significantly lower (p < 0.05) than those in the hollow, uASCs, and autograft groups. The advantages
of the intermittent dASCs group began to appear at week 8 after cell transplantation. Until the last time point, the stand/swing time ratio in
the intermittent dASCs (90.10 ± 2.25%) was significantly better (p < 0.05) than those in the hollow (75.51 ± 2.80%), uASCs (75.13 ± 3.47%), and
sustaining dASCs 7d groups (83.39 ± 3.68%). Data are expressed as means ± SEM. *p < 0.05, **p < 0.01, one-way ANOVA with Tukey’s post-test
or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; uASC, undifferentiated adipose-derived stem cell
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observed compared with the sustaining dASCs 7d group
(8942 ± 670/mm2 vs. 8461 ± 301/mm2) at week 12 after
cell transplantation (Fig. 6b, c).
At week 12 after cell transplantation, Toluidine Blue
staining and TEM results of regenerative nerves located
at the distal ends of implanted segments showed
Fig. 6 Histological evaluation of regenerated nerves after cell transplantation. a In the immunofluorescence (IF) photographs in the leftmost
column, regenerated axons stained with green fluorescence (wrapping or not wrapping around regenerated myelin sheaths labeled with red
fluorescence) were found at the midpoint of the implanted segments at week 6 after cell transplantation. The nuclei were stained with blue
fluorescence. The photographs in the middle and rightmost columns show Toluidine Blue staining and transmission electron microscopy (TEM)
images, respectively, of regenerated nerves located at the distal end of implanted segments at week 12 after cell transplantation. b,c The mean
density of myelinated nerve fibers in intermittent dASCs (15,520 ± 694/mm2) was significantly greater (p < 0.01) than those in the hollow (8575 ±
779/mm2), uASCs (7268 ± 637/mm2), and sustaining dASCs 7d groups (13,814 ± 658/mm2) at week 6 after cell transplantation. However, no
significant difference was observed compared with the sustaining dASCs 7d (8942 ± 670/mm2 vs. 8461 ± 301/mm2) at week 12 after cell transplantation.
d,e The mean diameter of myelinated nerve fibers and mean thickness of myelin sheath showed similar trends, i.e., those in the intermittent dASCs
(7.05 ± 0.51 μm in diameter and 1.53 ± 0.16 μm in thickness) were significantly greater (p < 0.05) than those in the hollow (4.43 ± 0.54 μm in diameter
and 1.03 ± 0.10 μm in thickness), uASCs (4.44 ± 0.53 μm in diameter and 0.91 ± 0.14 μm in thickness), and sustaining dASCs 7d groups (6.36 ± 0.39 μm in
diameter and 1.35 ± 0.13 μm in thickness), but significantly less (p < 0.05) than those in the autograft group (7.70 ± 0.53 μm in diameter and 1.78 ± 0.12 μm
in thickness). Data are expressed as means ± SEM. *p < 0.05, **p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC,
differentiated adipose-derived stem cell; n.s., no significant difference; uASC, undifferentiated adipose-derived stem cell
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relatively tenuous myelinated nerve fibers, and thinner
myelin sheaths were found in the hollow, uASCs, and
sustaining dASCs 7d groups, while thicker myelinated
nerve fibers and myelin sheaths were found in the inter-
mittent dASCs and autograft groups. In the hollow,
uASCs, and sustaining dASCs 7d groups, more fibrillar
connective tissue was seen among the myelinated or
non-myelinated nerve fibers, whereas little fibrillar con-
nective tissue was found in the intermittent dASCs and
autograft groups (Fig. 6a). The mean diameter of myelin-
ated nerve fibers and mean thickness of myelin sheaths
showed similar trends, i.e., those in the intermittent
dASCs (7.05 ± 0.51 μm in diameter and 1.53 ± 0.16 μm
in thickness) were significantly greater (p < 0.05) than
those in the hollow (4.43 ± 0.54 μm in diameter and 1.
03 ± 0.10 μm in thickness), uASCs (4.44 ± 0.53 μm in
diameter and 0.91 ± 0.14 μm in thickness), and sustain-
ing dASCs 7d groups (6.36 ± 0.39 μm in diameter and 1.
35 ± 0.13 μm in thickness), but significantly less (p < 0.
05) than those in the autograft group (7.70 ± 0.53 μm in
diameter and 1.78 ± 0.12 μm in thickness) (Fig. 6d, e).
Ultrasonic and histological evaluation of the gastrocnemius
Representative results of ultrasonic elastography of the
gastrocnemius at week 6 after cell transplantation are
shown in Fig. 7a to evaluate the target organ state of re-
generative nerves. The elastomeric map (left) and
Young’s modulus maps (right) are shown for each group.
Although the gastrocnemius elasticity ratio was not sig-
nificantly different among sustaining dASCs 7d (57.05 ±
4.59%), intermittent dASCs (60.79 ± 4.21%), and auto-
graft groups (64.36 ± 4.01%), these values were signifi-
cantly higher (p < 0.01) than those in the hollow (43.88
± 6.03%) and uASCs groups (45.81 ± 4.44%) (Fig. 7b). At
the twelfth week after cell transplantation, the gastrocne-
mius on the injured side showed visible atrophy in the
hollow and uASCs groups in comparison with the nor-
mal side. In contrast, the degree of gastrocnemius
atrophy was less pronounced in the other three groups
(Fig. 7a). The gastrocnemius wet weight ratio in inter-
mittent dASCs (71.46 ± 2.78%) was significantly greater
(p < 0.05) than those in the hollow (44.70 ± 3.51%),
uASCs (49.00 ± 3.15%), and sustaining dASCs 7d
groups (64.45 ± 2.91%) (Fig. 7c). Representative Mas-
son’s trichrome staining results of the gastrocnemius
are shown in Fig. 7a to evaluate recovery of denervated
muscles. All groups showed hyperplasia of blue-stained
collagen fibers distributed among muscle fibers stained
in red. The mean cross-sectional area of gastrocnemius
fibers in the intermittent dASCs group (1332.24 ± 60.
17 μm2) was significantly greater (p < 0.01) than those
in the hollow (568.04 ± 108.59 μm2), uASCs (807.80 ±
49.20 μm2), and sustaining dASCs 7d groups (1107.81
± 82.86 μm2) (Fig. 7d).
Electrophysiology
Representative CMAP oscillograms of each group at week
12 after cell transplantation are shown in Additional file 3
(Figure S3a). The amplitude ratio of CMAP in the inter-
mittent dASCs group (73.52 ± 4.06%) was significantly
lower (p < 0.01) than that in the autograft group (83.92 ±
7.40%), but was significantly higher (p < 0.05) than those
in the hollow (47.45 ± 1.66%), uASCs (47.34 ± 2.49%), and
sustaining dASCs 7d groups (64.67 ± 2.58%) (Additional
file 3: Figure S3b). Although the latency ratio of CMAP in
intermittent dASCs (1.37 ± 0.17) was not significantly
different compared with those in the sustaining dASCs 7d
(1.56 ± 0.10) and autograft groups (1.18 ± 0.06), the latter
were significantly lower (p < 0.01) than those in the hollow
(1.98 ± 0.23) and uASCs groups (1.98 ± 0.23) (Additional
file 3: Figure S3c).
Discussion
In this study, ASCs cultured in our laboratory showed
good capacity for multipotent differentiation, including
adipogenesis, osteogenesis, and chondrogenesis, as has
been reported for other MSCs (Fig. 1a–d). ASCs
expressed MSC surface markers and were negative for
expression of hematopoietic stem cell markers (Fig. 1e).
Previous studies have indicated biological advantages of
ASCs with regard to immunomodulatory and self-
renewal functions. Furthermore, the major protein
secreted by ASCs, bFGF, was shown to be an essential
factor for the induction of MSCs toward cells with a
SC-like phenotype [36, 37]. It has been demonstrated
previously that, although SCLCs induced by both
BMSCs and ASCs could enhance peripheral nerve re-
generation, ASCs had relatively lower invasiveness and
higher yields than BMSCs, and ASCs could be rapidly
amplified in vitro with lower immunogenicity [21]. In
addition, ASCs were more resistant to apoptosis in vitro
than BMSCs [38]. Taken together, these observations in-
dicated that ASCs had extensive advantages in differenti-
ation into SCLCs for repairing peripheral nerve injury
compared with BMSCs.
Although it was reported previously that MSCs differ-
entiate into SCLCs in a time-dependent manner, no
studies have been performed using intermittent induc-
tion methods to differentiate MSCs into SCLCs, as for
adipogenic differentiation [34, 35]. In the present study,
we applied an intermittent induction method to differen-
tiate ASCs into SCLCs in comparison with the trad-
itional sustaining induction method. To examine the
time dependency of traditional sustaining induction, we
divided the traditional method into three time periods:
sustaining dASCs 4d, 7d, and 10d (Fig. 1f ).
The key difference between intermittent induction and
traditional sustaining induction was the lack of bFGF
and PDGF in the incomplete induction medium, which
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replaced complete induction medium on day 4 after sus-
taining induction and was then replaced by complete in-
duction medium after 3 days. bFGF is a member of the
FGF family, members of which are involved in a number
of functions, including cell proliferation, migration, and
differentiation, and are essential factors in tissue devel-
opment, maintenance, and wound healing [39]. Some
studies have shown that bFGF supplementation was as-
sociated with maintenance of pluripotency and inhib-
ition of aging in MSCs [40]. Furthermore, bFGF is also a
major inducer of vascularization in MSCs [41, 42], and
upregulates the expression of PDGF receptors, which
have a synergistic effect on the promotion of
angiogenesis [43]. PDGF is a major mitogen for many
types of mesenchymal cells, including fibroblasts and
vascular smooth muscle cells [44]. In primary culture of
immature SCs, PDGF promotes cell proliferation by acti-
vating Erk pathways, but inhibits the expression of pro--
myelinating SC markers [45]. Moreover, the PDGF-
PDGFR signaling system is involved in fibrosis and is
believed to play a role in promoting the proliferation of
cells with a fibroblast phenotype [46, 47]. Therefore, we
believe that the sustained presence of bFGF and PDGF
in the induction medium may preserve the multipoten-
tial differentiation of MSCs, such as adipocytes,
fibroblast-like cells, endothelial-like cells, and even
Fig. 7 Ultrasonic and histological evaluation of the gastrocnemius. a Representative results of ultrasonic elastography of the gastrocnemius at
week 6 after cell transplantation are shown in the first row. The elastomeric map (left) and Young’s modulus maps (right) are shown for each
group. In the photographs in the middle row, the gastrocnemius on the injured side shows visible atrophy in the hollow and uASCs groups
compared with the normal side at week 12 after cell transplantation; in contrast, the other three groups were less pronounced. Representative
Masson’s trichrome staining results of the gastrocnemius are shown in the bottom row. All groups showed hyperplasia of blue-stained collagen
fibers distributed among muscle fibers stained in red. b Although the gastrocnemius elasticity ratio was not significantly different among sustaining
dASCs 7d (57.05 ± 4.59%), intermittent dASCs (60.79 ± 4.21%), and autograft groups (64.36 ± 4.01%), these values were significantly higher (p < 0.01)
than those in the hollow (43.88 ± 6.03%) and uASCs groups (45.81 ± 4.44%). c At the twelfth week after cell transplantation, the gastrocnemius wet
weight ratio in intermittent dASCs (71.46 ± 2.78%) was significantly greater (p < 0.05) than those in the hollow (44.70 ± 3.51%), uASCs (49.00 ± 3.15%),
and sustaining dASCs 7d groups (64.45 ± 2.91%). d The mean cross-sectional area of gastrocnemius fibers in the intermittent dASCs group (1332.24 ±
60.17 μm2) was significantly greater (p < 0.01) than those in the hollow (568.04 ± 108.59 μm2), uASCs (807.80 ± 49.20 μm2), and sustaining dASCs 7d
groups (1107.81 ± 82.86 μm2) at the twelfth week after cell transplantation. Data are expressed as means ± SEM. *p < 0.05, **p < 0.01, one-way ANOVA
with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference; uASC, undifferentiated
adipose-derived stem cell
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neuron-like cells, etc., thus reducing the induction effi-
ciency of SCLCs.
Forskolin, an activator of adenylate cyclase extracted
from the plant Coleus forskholii, is widely used in cell
physiology to increase intracellular cyclic adenosine
monophosphate (cAMP) levels and to promote cellular re-
sponses to neurotrophins [27, 48]. In some diseases that
cause hypomyelination of the peripheral nervous system,
the elevation of cAMP levels following treatment with
forskolin is sufficient to restore myelination [49, 50]. This
phenomenon highlights the importance of forskolin in the
differentiation of myelinating SCs, and therefore the
persistence of forskolin in the induction medium is benefi-
cial to the maturation of SCLCs. HRG is a subtype of
neuregulin, a genetic regulatory factor in the nervous sys-
tem, and is also an important axon-derived signal that
prevents the apoptosis of SC precursors, while regulating
and controlling the formation of myelin and SCs [51, 52].
Therefore, the synergistic effect of HRG persisting
throughout the whole induction process with forskolin
can reduce apoptosis of SCLCs, which are successfully dif-
ferentiated, and can induce SCLCs to differentiate into
myelinating SCs to the maximum extent.
We also found that it is difficult to maintain the
Schwann-like morphology of cells if they are always kept
in incomplete induction medium. This result was con-
sistent with the suggestion that bFGF is a crucial factor
for maintaining Schwann-like morphology of cells [53].
Although the intermittent induction method achieved
good results both in vitro and in vivo, the changes in cell
signaling pathways induced by incomplete induction
medium during differentiation remain unclear. We
hypothesize that ASCs/SCLCs induce a transient mem-
ory of cellular differentiation during intermittent induc-
tion by incomplete induction medium, promoting ASC/
SCLC differentiation into cellular phenotypes of transi-
ent memory more efficiently and stably on restimulation
in complete induction medium.
Immunofluorescence staining showed that the rates of
S100-positive cells increased in all groups with the
length of induction period. Although the rate of S100-
positive cells was higher in the intermittent dASCs
group compared with the sustaining dASCs 4d and 7d
groups, there was no significant difference between
intermittent dASCs and sustaining dASCs 10d groups
(Fig. 2a, b). However, the lack of difference between
them was not absolute, because many of the sustaining
dASCs that failed to differentiate into SCLCs underwent
apoptosis, the number of surviving cells in sustaining
dASCs groups decreased gradually with induction time,
and then the rate of S100-positive cells increased indir-
ectly (Fig. 2b, d). In fact, the success rate of differenti-
ation in the sustaining dASCs 10d group was not only
poorer than that of intermittent dASCs, it was even
poorer than that of the sustaining dASCs 7d group. The
number of NGFR p75-positive cells was not significantly
different among all groups, even between uASCs and
SCs (Fig. 2a, c). The high-affinity neurotrophic receptors,
TrkA and TrkB, and the low-affinity neurotrophic recep-
tor, NGFR p75, are major receptors of NGF [54, 55].
However, a recent study indicated that NGFR p75 and
TrkA/TrkB exist not only in neurons and glial cells, but
are also expressed in many other cell types, including
MSCs [56]. As a member of the tumor necrosis factor
receptor (TNFR) superfamily, it is generally accepted
that NGFR p75 initiates apoptosis following cell injury
[57]. This might explain the observed lack of difference
in the rate of NGFR p75-positive cells between groups
in the present study.
The qRT-PCR results showed that the level of NGFR
p75 mRNA expression increased with the induction
period and the maximum was reached on the seventh
day of sustaining induction, with a subsequent decrease,
which may have been related to negative feedback regu-
lation after activation of the receptor. The level of NGFR
p75 mRNA expression in the intermittent dASCs was
not significantly different from those in sustaining
dASCs 7d and SCs, which were higher than those in the
other three groups. This may have been because cells in
the intermittent dASCs group were in good condition,
most NGFR p75 receptors had not been activated, and
the cell apoptosis program had not been activated, lead-
ing to upregulation of NGFR p75 mRNA expression by
negative feedback regulation (Fig. 3a). P0, the most im-
portant component of peripheral nerve myelin, is con-
sidered to be a crucial marker of matured SCs, which
are myelinating Schwann cells [58]. In contrast, GFAP is
a marker of non-myelinating SCs [16]. Intermittent
dASCs showed a greater increase in P0 mRNA expres-
sion compared with sustaining dASCs 4d and 10d, but
there was no significant difference compared with the
sustaining dASCs 7d group (Fig. 3b). However, GFAP
mRNA expression in intermittent dASCs was not
different from those in all sustaining inducing groups
(Fig. 3c). As expected, the above results indicated that
the SCLCs of intermittent dASCs and sustaining dASCs
7d groups were closer to myelinating SCs at the transcrip-
tional level than the other groups. This conclusion was
also confirmed by in vivo experiments indicating that the
density of myelinated nerve fibers, the mean diameter of
myelinated nerve fibers, and the mean thickness of the
myelin sheath in intermittent dASCs and sustaining
dASCs 7d groups were superior to those in hollow and
uASCs groups after cell transplantation (Fig. 6a–e).
qRT-PCR and ELISA results indicated that NGF ex-
pression at transcriptional and translational levels in the
intermittent dASCs and sustaining dASCs 7d groups
were significantly higher than those in uASCs and
Sun et al. Stem Cell Research & Therapy  (2018) 9:133 Page 16 of 20
sustaining dASCs 4d and 10d groups (Additional file 2:
Figure S2a and Fig. 3d). A previous study indicated that
the presence of NGF in adipose tissue was crucial for the
outgrowth of PC12 cell axons [59]. A similar phenomenon
was also observed in the present study, in that DRG of the
intermittent dASCs and sustaining dASCs 7d groups with
higher NGF expression levels showed longer axon length
than uASCs, and sustaining dASCs 4d and 10d groups in
the Transwell® system (Fig. 4a, b). NGF also plays an im-
portant role in the development of nociceptive neurons of
the DRG, as well as in the production and maintenance of
neuropathic pain in a variety of experimental animal
models of pain [60, 61]. At weeks 2 and 4 following cell
transplantation, the stand/swing time ratios in the inter-
mittent dASCs and sustaining dASCs 7d groups were
significantly lower than those in the other three groups
(Fig. 5a, c). This may have been because of the higher level
of NGF secretion in these two groups at an early stage fol-
lowing cell transplantation, resulting in severe pain in the
limb on the injured side, and thus the rats intentionally re-
duced the time that this limb touched the ground.
qRT-PCR and ELISA results also indicated equivalent
BDNF expression both transcriptionally and translation-
ally in the intermittent dASCs group and the sustaining
dASCs 7d group, which were significantly higher than
those in the uASCs group, other sustaining induction
groups, and SCs (Additional file 2: Figure S2b and Fig.
3e). The BDNF/TrkB pathway is important for the for-
mation of actin waves, which are indispensable for axon
regeneration [62]. Simultaneously, BDNF increases
cAMP levels during nerve regeneration, and upregulates
the CREB-cjun-STAT3-Gap-43 pathway, which is associ-
ated with the intrinsic capacity of axonal growth. That
is, BDNF delays degradation of distal nerves, while en-
hancing and maintaining the intrinsic capacity of axonal
regeneration at a high level [63]. Finally, the above ef-
fects of BDNF were reflected in recovery of the SFI and
neural electrophysiological evaluation in vivo. The SFI
(Fig. 5a, b) and amplitude ratio of CMAP (Additional file
3: Figure S3a and b) in the intermittent dASCs group
with a higher expression level of BDNF were similar to
the autograft group, and significantly superior to the
other groups.
CNTF from the chicken ciliary ganglion is a member
of the interleukin-6 cytokine family [64, 65]. qRT-PCR
and ELISA results showed that the intermittent dASCs
and sustaining dASCs 7d groups had similar expression
of CNTF at both transcriptional and protein secretion
levels, which were significantly higher than those in the
uASCs group and other sustaining induction groups
(Additional file 2: Figure S2c and Fig. 3g). As an effective
survival factor, CNTF can reduce tissue destruction dur-
ing inflammation and protect damaged neurons from
degeneration and necrosis [66]. This explains why the
density of myelinated nerve fibers in intermittent dASCs
and sustaining dASCs 7d groups were significantly
greater than those in the hollow and uASCs groups at
both the early stage (6 weeks after cell transplantation)
and late stage (12 weeks after cell transplantation), but
especially at the early stage (Fig. 6a–c). Moreover, CNTF
has the ability to prevent scar tissue formation in the
presence of other factors, such as BDNF [67]. This syn-
ergistic effect of CNTF with BDNF began to appear at
8 weeks after cell transplantation, resulting in the signifi-
cantly higher stand/swing time ratio in the intermittent
dASCs and sustaining dASCs 7d groups compared with
the hollow and uASCs groups (Fig. 5c), indicating that
the former two groups were less likely to generate
neuropathic pain caused by hypertrophic scar formation
during nerve regeneration. As a consequence, the rats in
the intermittent dASCs and sustaining dASCs 7d groups
did not intentionally reduce the time the limb on the in-
jured side touched the ground, and the reduction of con-
tact time was caused by haphalgesia.
GDNF was first discovered in the culture medium of
glioma cell lines and is considered a member of the
transforming growth factor-β (TGF-β) family [68]. Al-
though GDNF is significantly more effective than BDNF
in promoting axonal regeneration, a synergistic effect of
BDNF and GDNF was observed in the treatment of tibial
nerve injury in adult rats, which significantly increased
the number of motor neurons in corresponding spinal
segments [69]. At 6 weeks after cell transplantation, our
study also indicated a guiding and synergistic effect
through ultrasonic elasticity evaluation of the target
organ, i.e., the gastrocnemius. Rats of the intermittent
dASCs and sustaining dASCs 7d groups with higher ex-
pression levels of both GDNF and BDNF (Fig. 3e, f ) had
superior gastrocnemius elasticity than those in the hol-
low and uASCs groups (Fig. 7a, b). These observations
indirectly demonstrated that the cells of intermittent
dASCs and sustaining dASCs 7d groups were able to
rapidly restore innervation of the target organ (gastro-
cnemius), thereby preventing muscle atrophy. Similarly,
histological evaluation of the target organ (muscles) in-
directly confirmed the guiding and synergistic effects of
GDNF and BDNF. At 12 weeks after cell transplantation,
both gastrocnemius wet weight ratio and cross-sectional
area of gastrocnemius fibers of rats in the intermittent
dASCs groups with higher expression of GDNF and
BDNF (Fig. 3e, f ) were superior to those in the other
groups except the autograft group (Fig. 7a, c, d). GDNF
can also relieve allodynia and hyperalgesia at the level of
sensory neurons in the DRG [70]. In comparison with
peptidergic neurons, which are NGF-dependent nocicep-
tive neurons, the C fibers of non-peptidergic neurons in
the DRG rely on the neurotrophin GDNF family as anal-
gesic factors [61]. The mutual regulation between GDNF
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and NGF eventually resulted in an initial decrease in the
stand/swing time ratio followed by an increase in the
intermittent dASCs group (Fig. 5c).
Conclusion
The results of the present study indicated that intermit-
tent induction is a more efficient method of inducing
the differentiation of ASCs into SCLCs in comparison
with traditional methods of sustaining induction. In
addition, SCLCs induced by this method were phenotyp-
ically close to mature myelinating SCs and were capable
of secreting neurotrophins and promoting DRG axon re-
generation in vitro. Furthermore, SCLCs induced by the
intermittent induction method could repair sciatic nerve
defects in rat models in vivo more effectively than trad-
itional methods. Thus, intermittent induction provides a
novel strategy for obtaining seed cells for use in nerve
tissue engineering.
Additional files
Additional file 1: Figure S1. Schematic diagram of the Transwell®
system. DRGs were seeded in the lower chambers of the system, which
included six 24-mm diameter, 0.4-μm pore polyester membrane inserts in
a six-well plate. The uASCs, dASCs, and SCs were seeded in the upper
inserts of the Transwell® system. (PDF 533 kb)
Additional file 2: Figure S2. Relative mRNA expression levels of
neurotrophins in each group of cells. There were no significant
differences in NGF (a), BDNF (b), and CNTF (c) mRNA expression levels
between intermittent dASCs and sustaining dASCs 7d groups, but all
were significantly higher (p < 0.01) compared with sustaining dASCs
4d and 10d groups. Data are expressed as means ± SEM. **p < 0.01, n.s.
represents no significant difference, one-way ANOVA with Tukey’s
post-test or Dunnett T3’s post-test. (PDF 1601 kb)
Additional file 3: Figure S3. Electrophysiological examination. (a)
Representative CMAP oscillograms of each group at week 12 after cell
transplantation. (b) The amplitude ratio of CMAP in the intermittent dASCs
group (73.52 ± 4.06%) was significantly lower (p < 0.01) than that in the
autograft group (83.92 ± 7.40%), but was significantly higher (p < 0.05) than
those in the hollow (47.45 ± 1.66%), uASCs (47.34 ± 2.49%), and sustaining
dASCs 7d groups (64.67 ± 2.58%). (c) Although the latency ratio of CMAP in
intermittent dASCs (1.37 ± 0.17) was not significantly different compared
with those in the sustaining dASCs 7d (1.56 ± 0.10) and autograft groups
(1.18 ± 0.06), the latter were significantly lower (p < 0.01) than those in the
hollow (1.98 ± 0.23) and uASCs groups (1.98 ± 0.23). Data are expressed as
means ± SEM. *p < 0.05, **p < 0.01, n.s. represents no significant difference,
one-way ANOVA with Tukey’s post-test or Dunnett T3’s post-test. (PDF 1201 kb)
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